435 results on '"Jiang, Zhongxing"'
Search Results
2. Clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia
3. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions
4. Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
5. Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing
6. Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation
7. FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma
8. Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China
9. IMM0306, a fusion protein of CD20 mAb with the CD47 binding domain of SIRPα, exerts excellent cancer killing efficacy by activating both macrophages and NK cells via blockade of CD47-SIRPα interaction and FcɣR engagement by simultaneously binding to CD47 and CD20 of B cells
10. Genetic mutation signature for relapse prediction in normal karyotype acute myeloid leukemia
11. Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1
12. A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody
13. Early progression is associated with worse survival in patients with Waldenström’s macroglobulinemia
14. Cysteine- and glycine-rich protein 1 predicts prognosis and therapy response in patients with acute myeloid leukemia
15. Targeting TIGIT for cancer immunotherapy: recent advances and future directions
16. Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China
17. WITHDRAWN: SPOP Promotes Acute Myeloid Leukemia Initiation and Development Through miR-183-Mediated METAP2 Inhibition
18. CCL17 acts as an antitumor chemokine in micromilieu‐driven immune skewing
19. Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation
20. Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis
21. Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
22. Prognostic prediction of novel risk scores (AML-DRG and AML-HCT-CR) in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation
23. Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cells
24. Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level
25. Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma
26. SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the “don’t eat me” signal and activating the “eat me” signal
27. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype
28. Research progress on dendritic cell vaccines in cancer immunotherapy
29. GM-CSF impairs erythropoiesis by disrupting erythroblastic island formation via macrophages
30. Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study
31. Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes
32. Vesicular formation regulated by ERK/MAPK pathway mediates human erythroblast enucleation
33. Unbiased Single‐Cell Sequencing of Hematopoietic and Immune Cells from Aplastic Anemia Reveals the Contributors of Hematopoiesis Failure and Dysfunctional Immune Regulation
34. Efficacy, Safety, and Survival Findings after Long-Term Follow-up from ZGJAK002, a Phase 2 Study Comparing Jaktinib 100 Mg Twice Daily with 200 Mg Once Daily for Myelofibrosis (MF)
35. MiR-150-5p regulate T cell activation in severe aplastic anemia by targeting Bach2
36. Efficacy, safety, and survival findings after long‐term follow‐up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.
37. Unbiased Single‐Cell Sequencing of Hematopoietic and Immune Cells from Aplastic Anemia Reveals the Contributors of Hematopoiesis Failure and Dysfunctional Immune Regulation.
38. Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
39. A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
40. Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment
41. Targeting CD47 for cancer immunotherapy
42. A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation
43. Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting
44. Targeted single‐cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis‐resistant state in hematologic malignancies
45. Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes
46. IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy
47. S212: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE-2 OR HIGH RISK MYELOFIBROSIS
48. P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL
49. Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
50. Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.